Leukaemia Foundation

Leukaemia, Lymphoma, Myeloma & Related Blood Disorders.

Change Your Location:

Research Partnerships

The Leukaemia Foundation is fortunate to have partnered with the following bodies to fund vital research into the causes, epidemiology, diagnosis and treatment, psychosocial impact and ultimately cures for leukaemias, lymphomas, myeloma and related blood disorders.

Leukaemia Foundation Research Unit

The Leukaemia Foundation Research Unit at the Queensland Institute of Medical Research was established to find cures for blood cancers and related disorders and deliver the benefits to patients as quickly as possible.

Read More about: Leukaemia Foundation Research Unit

ALLG Discovery Centre (formerly the ALLG Tissue Bank)

The ALLG Discovery Centre is a temperature controlled facility for storing clinical tissue samples to be used in approved research. The samples are human tissue samples collected from the blood, bone marrow and other body organs of patients across Australia with leukaemia, lymphoma, myeloma, MDS, MPN, or related blood disorders.

Read More about: ALLG Discovery Centre (formerly the ALLG Tissue Bank)

Partnership with Cancer Australia

Since 2009, the Leukaemia Foundation has partnered with Cancer Australia to advance research into blood cancers. We are currently partnering in funding research to lymphoma and myelodysplastic syndromes.

Read More about: Partnership with Cancer Australia

Cure Cancer Australia Post Doctoral Partnership

The Leukaemia Foundation collaborates with the Cure Cancer Australia Foundation to maximise outcomes for researchers and patients

Read More about: Cure Cancer Australia Post Doctoral Partnership

New Directions in Leukaemia Research Partnership

The Leukaemia Foundation has hosted the biennial NDLR Conference series since its inception in 2006, since then, NDLR has gained an reputation for bringing together representatives of the international research community to share ideas and enrich understanding of the current concepts in leukaemia research and therapies.

Read More about: New Directions in Leukaemia Research Partnership